• 1. Alternative donor substrates for inverting and retaining glycosyltransferases?
  Luke L. Lairson,Warren W. Wakarchuk Chem. Commun., 2007, 365-367
• 2. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535
• 3. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 4. An investigation into the origin of variations in photovoltaic performance using D–D–π–A and D–A–π–A triphenylimidazole dyes with a copper electrolyte?
  Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789
• 5. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzamides
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzamides

Comprehensive Overview of 2-{N-methyl-1-[4-(morpholine-4-sulfonyl)phenyl]formamido}acetic acid (CAS No. 620103-27-7)

2-{N-methyl-1-[4-(morpholine-4-sulfonyl)phenyl]formamido}acetic acid (CAS No. 620103-27-7) is a specialized organic compound that has garnered significant attention in pharmaceutical and biochemical research due to its unique structural features and potential applications. This compound, often referred to by its CAS number 620103-27-7, belongs to a class of sulfonamide derivatives, which are widely studied for their bioactive properties. The presence of both morpholine and sulfonyl groups in its structure makes it a promising candidate for drug discovery and development.

One of the key reasons for the growing interest in 2-{N-methyl-1-[4-(morpholine-4-sulfonyl)phenyl]formamido}acetic acid is its potential role in modulating enzyme activity. Researchers have explored its interactions with various biological targets, particularly those involved in inflammatory pathways. The compound's N-methyl and acetic acid moieties contribute to its solubility and bioavailability, which are critical factors in drug design. Additionally, the morpholine-4-sulfonyl group enhances its ability to bind to specific protein sites, making it a valuable tool for studying signal transduction mechanisms.

In recent years, the demand for sulfonamide-based compounds has surged, driven by their applications in treating a range of conditions. 2-{N-methyl-1-[4-(morpholine-4-sulfonyl)phenyl]formamido}acetic acid is no exception, as it has been investigated for its potential anti-inflammatory and antimicrobial properties. These studies align with current trends in precision medicine, where researchers seek to develop targeted therapies with minimal side effects. The compound's CAS number 620103-27-7 is frequently searched in academic databases, reflecting its relevance in ongoing research.

The synthesis of 2-{N-methyl-1-[4-(morpholine-4-sulfonyl)phenyl]formamido}acetic acid involves multi-step organic reactions, including sulfonylation and amidation. These processes require careful optimization to ensure high yield and purity, which are essential for its use in biological assays. The compound's morpholine ring is particularly noteworthy, as it is a common pharmacophore in many FDA-approved drugs. This structural feature has led to speculation about its potential as a scaffold for developing new therapeutics.

From an industrial perspective, CAS No. 620103-27-7 is often discussed in the context of green chemistry and sustainable synthesis. Researchers are exploring eco-friendly methods to produce this compound, such as catalytic reactions and solvent-free conditions. These efforts resonate with the global push toward environmentally responsible practices in chemical manufacturing. The compound's acetic acid group also makes it amenable to further derivatization, opening doors for the creation of novel analogs with enhanced properties.

In summary, 2-{N-methyl-1-[4-(morpholine-4-sulfonyl)phenyl]formamido}acetic acid (CAS No. 620103-27-7) represents a fascinating area of study at the intersection of chemistry and biology. Its unique structure, combined with its potential therapeutic applications, makes it a subject of ongoing research. As the scientific community continues to uncover its mechanisms of action, this compound may pave the way for innovative treatments in the years to come.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)